Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing
Organoid-based studies have revolutionized in vitro preclinical research and hold great promise for the cancer research field, including prostate cancer (PCa). However, experimental variability in organoid drug testing complicates reproducibility. For example, we observed PCa organoids to be less af...
Main Authors: | Annelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, Pim J. French, Wytske M. van Weerden, Martin E. van Royen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/11/1572 |
Similar Items
-
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids
by: Annelies Van Hemelryk, et al.
Published: (2023-05-01) -
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
by: Annelies Van Hemelryk, et al.
Published: (2022-11-01) -
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
by: Mohammad Waseem, et al.
Published: (2024-01-01) -
Living biobank-based cancer organoids: prospects and challenges in cancer research
by: Haixin Li, et al.
Published: (2022-07-01) -
The Organoid Era Permits the Development of New Applications to Study Glioblastoma
by: Francesco Andreatta, et al.
Published: (2020-11-01)